AstraZeneca builds pipeline with $232 million Synairgen asthma deal – Fox Business


Reuters UK

AstraZeneca builds pipeline with $232 million Synairgen asthma deal
Fox Business
AstraZeneca has struck a deal worth up to $232 million in milestone payments to acquire rights to a drug from Synairgen for treating respiratory tract viral infections in patients with severe asthma. Britain's second-biggest drugmaker – subject of a
AstraZeneca extends global shopping spree with $232M asthma drug dealFierceBiotech
Synairgen breathes easier with $225M from Astrazeneca for its asthma drugBioWorld Online

all 35 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.